Lorente F, Romo A, Laffond E, Dávila I
Departamento de Pediatría, Hospital Clínico y Universitario de Salamanca.
Allergol Immunopathol (Madr). 1998 May-Jun;26(3):101-13.
Allergic diseases, particularly asthma and asthma equivalents, are among the most frequent disorders seen in the pediatric clinic. Approximately 25% of children from developed countries have presented wheezing in recent years, and half of these children later experience major asthma attacks. Likewise, 25% of children between 8 and 11 years have at some time used beta agonists and at least 10% of them use preventive asthma medication. Prevention measures for allergic asthma include: 1) avoiding allergic sensitization; 2) avoiding the presentation of disease in sensitized patients; and 3) preventing symptoms after the disease has appeared. Allergic diseases have a multifactorial origin that includes genetic, perinatal, and specific and non-specific environmental factors. From a genetic point of view, asthma is a multifactorial and heterogeneous pathology with a variable degree of penetration and phenocopy. Allergy is more frequent among the offspring of atopic parents. Genetic variations in different chromosomes affect molecules and receptors involved in atopy: IgE elevation, Fce1 receptor and chromosome 11; IL-4 and chromosome 3; gamma interferon and chromosome 12; TcR a/d receptor and chromosome 14; TcR-beta and chromosome 7; and the main histocompatibility complex HLA I and II and chromosome 6. Likewise, it has been confirmed that genetic variants affect structures in the impact organs, such as the beta 2 receptors of IL-4 soluble receptors, which favor bronchial hyperreactivity. Recently, somatometric measures have been related (low weight and large head circumference at birth) with a later increase in IgE and the occurrence of asthma. The environmental factors most closely involved in the occurrence of asthma are: diet (early exposure to sensitizing foods); domestic, outside, and occupational seroallergens; pollution (particularly smoking and urban and industrial pollution); and infections, particularly viral infections. In the present study, the methods used for the early identification of children at risk are evaluated, as well as the role of the primary care pediatrician in the early detection of allergic children and the interventions that they carry out. Finally, an analysis is made of the preventive measures that should be taken in children at risk of allergic disease, particularly: 1) increasing awareness of health, 2) reduction of exposure to smoking. 3) reduction of urban and industrial pollution, 4) delayed introduction of certain foods, reduction in the level of domestic allergens, 6) control of infections, and 7) pharmacological measures designed to prevent the occurrence of asthma in children.
过敏性疾病,尤其是哮喘和类哮喘疾病,是儿科门诊中最常见的疾病之一。近年来,发达国家约25%的儿童出现过喘息症状,其中半数儿童后来经历了严重的哮喘发作。同样,8至11岁的儿童中有25%曾在某些时候使用过β受体激动剂,其中至少10%的儿童使用预防性哮喘药物。过敏性哮喘的预防措施包括:1)避免过敏致敏;2)避免致敏患者发病;3)在疾病出现后预防症状。过敏性疾病有多种成因,包括遗传、围产期以及特定和非特定的环境因素。从遗传学角度来看,哮喘是一种多因素、异质性的病理状态,具有不同程度的外显率和表型模拟。过敏在特应性父母的后代中更为常见。不同染色体上的基因变异会影响参与特应性的分子和受体:IgE升高、Fce1受体与11号染色体;IL-4与3号染色体;γ干扰素与12号染色体;TcR a/d受体与14号染色体;TcR-β与7号染色体;以及主要组织相容性复合体HLA I和II与6号染色体。同样,已经证实基因变异会影响受累器官的结构,如IL-4可溶性受体的β2受体,这会导致支气管高反应性。最近,人体测量指标(出生时体重低和头围大)与后期IgE升高及哮喘的发生有关。与哮喘发生密切相关的环境因素有:饮食(过早接触致敏食物);家庭、户外和职业性血清过敏原;污染(尤其是吸烟以及城市和工业污染);以及感染,特别是病毒感染。在本研究中,评估了用于早期识别高危儿童的方法,以及基层儿科医生在早期发现过敏儿童及其所采取干预措施中的作用。最后,分析了对有过敏性疾病风险的儿童应采取的预防措施;特别是:1)提高健康意识;2)减少接触吸烟;3)减少城市和工业污染;4)推迟引入某些食物;5)降低家庭过敏原水平;6)控制感染;7)采取旨在预防儿童哮喘发生的药物措施。